LB907 Sequelae of pediatric allogeneic hematopoietic stem cell transplantation

Abstract

Pediatric patients are at risk for adverse drug reactions, and oncologic patients are at an even higher risk. (1) This study aims to describe and quantify the long-term dermatologic sequelae and drug reactions in patients who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) as children. 273 patients who received allo-HSCT as children from the period 01/27/2002- 01/27/2022 at Duke University Hospital were identified. All patient visits from the period of 01/1996-01/2020 were obtained via the Duke Enterprise Data Unified Content Explorer (DEDUCE).